{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:00:53Z","timestamp":1793628053186,"version":"4.5.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01 NS092521"],"award-info":[{"award-number":["P01 NS092521"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F30 HL140871"],"award-info":[{"award-number":["F30 HL140871"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007171"],"award-info":[{"award-number":["T32 GM007171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["17 CVD 03"],"award-info":[{"award-number":["17 CVD 03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18PRE34060061"],"award-info":[{"award-number":["18PRE34060061"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10456-020-09736-8","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T20:03:39Z","timestamp":1595621019000},"page":"651-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Novel Murine Models of Cerebral Cavernous Malformations"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-2565","authenticated-orcid":false,"given":"Matthew R.","family":"Detter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-6845","authenticated-orcid":false,"given":"Robert","family":"Shenkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R.","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Lightle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Gallione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-602X","authenticated-orcid":false,"given":"Issam A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-6671","authenticated-orcid":false,"given":"Douglas A.","family":"Marchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"issue":"6","key":"9736_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/nejm198808113190605","volume":"319","author":"D Rigamonti","year":"1988","unstructured":"Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT et al (1988) Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 319(6):343\u2013347. https:\/\/doi.org\/10.1056\/nejm198808113190605","journal-title":"N Engl J Med"},{"issue":"4","key":"9736_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820\u2013823","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"9736_CR3","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/hmg\/8.12.2325","volume":"8","author":"T Sahoo","year":"1999","unstructured":"Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG et al (1999) Mutations in the gene encoding KRIT1, a Krev-1\/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8(12):2325\u20132333","journal-title":"Hum Mol Genet"},{"issue":"2","key":"9736_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/13815","volume":"23","author":"S Laberge-le Couteulx","year":"1999","unstructured":"Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M et al (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23(2):189\u2013193. https:\/\/doi.org\/10.1038\/13815","journal-title":"Nat Genet"},{"issue":"6","key":"9736_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/380314","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T et al (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73(6):1459\u20131464. https:\/\/doi.org\/10.1086\/380314","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9736_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1086\/381718","volume":"74","author":"C Denier","year":"2004","unstructured":"Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A et al (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74(2):326\u2013337. https:\/\/doi.org\/10.1086\/381718","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9736_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M et al (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76(1):42\u201351. https:\/\/doi.org\/10.1086\/426952","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9736_CR8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","volume":"36","author":"J Gault","year":"2005","unstructured":"Gault J, Shenkar R, Recksiek P, Awad IA (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36(4):872\u2013874. https:\/\/doi.org\/10.1161\/01.STR.0000157586.20479.fd","journal-title":"Stroke"},{"key":"9736_CR9","doi-asserted-by":"publisher","unstructured":"Gault J, Awad IA, Recksiek P, Shenkar R, Breeze R, Handler M et al (2009) Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 65(1):138\u2013144; discussion 44\u201345. https:\/\/doi.org\/10.1227\/01.neu.0000348049.81121.c1","DOI":"10.1227\/01.neu.0000348049.81121.c1"},{"issue":"5","key":"9736_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18(5):919\u2013930. https:\/\/doi.org\/10.1093\/hmg\/ddn430","journal-title":"Hum Mol Genet"},{"issue":"16","key":"9736_CR11","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","volume":"23","author":"DA McDonald","year":"2014","unstructured":"McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S et al (2014) Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet 23(16):4357\u20134370. https:\/\/doi.org\/10.1093\/hmg\/ddu153","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9736_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3171\/jns.1994.80.3.0422","volume":"80","author":"JM Zabramski","year":"1994","unstructured":"Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP et al (1994) The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 80(3):422\u2013432. https:\/\/doi.org\/10.3171\/jns.1994.80.3.0422","journal-title":"J Neurosurg"},{"issue":"2","key":"9736_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s1474-4422(15)00303-8","volume":"15","author":"MA Horne","year":"2016","unstructured":"Horne MA, Flemming KD, Su IC, Stapf C, Jeon JP, Li D et al (2016) Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 15(2):166\u2013173. https:\/\/doi.org\/10.1016\/s1474-4422(15)00303-8","journal-title":"Lancet Neurol"},{"issue":"3","key":"9736_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s1474-4422(12)70004-2","volume":"11","author":"R Al-Shahi Salman","year":"2012","unstructured":"Al-Shahi Salman R, Hall JM, Horne MA, Moultrie F, Josephson CB, Bhattacharya JJ et al (2012) Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol 11(3):217\u2013224. https:\/\/doi.org\/10.1016\/s1474-4422(12)70004-2","journal-title":"Lancet Neurol"},{"issue":"2","key":"9736_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J et al (2009) The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15(2):177\u2013184. https:\/\/doi.org\/10.1038\/nm.1911","journal-title":"Nat Med"},{"issue":"20","key":"9736_CR16","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1074\/jbc.C900009200","volume":"284","author":"LE Crose","year":"2009","unstructured":"Crose LE, Hilder TL, Sciaky N, Johnson GL (2009) Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem 284(20):13301\u201313305. https:\/\/doi.org\/10.1074\/jbc.C900009200","journal-title":"J Biol Chem"},{"issue":"4","key":"9736_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.20091258","volume":"207","author":"RA Stockton","year":"2010","unstructured":"Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207(4):881\u2013896. https:\/\/doi.org\/10.1084\/jem.20091258","journal-title":"J Exp Med"},{"issue":"16","key":"9736_CR18","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1074\/jbc.C109.097220","volume":"285","author":"AL Borikova","year":"2010","unstructured":"Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S et al (2010) Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285(16):11760\u201311764. https:\/\/doi.org\/10.1074\/jbc.C109.097220","journal-title":"J Biol Chem"},{"issue":"7597","key":"9736_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R et al (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature 532(7597):122\u2013126. https:\/\/doi.org\/10.1038\/nature17178","journal-title":"Nature"},{"issue":"1","key":"9736_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15252\/emmm.201505433","volume":"8","author":"R Cuttano","year":"2015","unstructured":"Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E et al (2015) KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med 8(1):6\u201324. https:\/\/doi.org\/10.15252\/emmm.201505433","journal-title":"EMBO Mol Med"},{"issue":"7654","key":"9736_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N et al (2017) Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545(7654):305\u2013310. https:\/\/doi.org\/10.1038\/nature22075","journal-title":"Nature"},{"issue":"3","key":"9736_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1083\/jcb.201303044","volume":"202","author":"E Faurobert","year":"2013","unstructured":"Faurobert E, Rome C, Lisowska J, Manet-Dupe S, Boulday G, Malbouyres M et al (2013) CCM1-ICAP-1 complex controls beta1 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol 202(3):545\u2013561. https:\/\/doi.org\/10.1083\/jcb.201303044","journal-title":"J Cell Biol"},{"issue":"4","key":"9736_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/hmg\/11.4.389","volume":"11","author":"JS Zawistowski","year":"2002","unstructured":"Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11(4):389\u2013396. https:\/\/doi.org\/10.1093\/hmg\/11.4.389","journal-title":"Hum Mol Genet"},{"issue":"28","key":"9736_CR24","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1073\/pnas.1000132107","volume":"107","author":"J Wustehube","year":"2010","unstructured":"Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U et al (2010) Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci USA 107(28):12640\u201312645. https:\/\/doi.org\/10.1073\/pnas.1000132107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"9736_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm.4169","volume":"22","author":"HJ Zhou","year":"2016","unstructured":"Zhou HJ, Qin L, Zhang H, Tang W, Ji W, He Y et al (2016) Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med 22(9):1033\u20131042. https:\/\/doi.org\/10.1038\/nm.4169","journal-title":"Nat Med"},{"issue":"3","key":"9736_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2018-06-856062","volume":"133","author":"MA Lopez-Ramirez","year":"2019","unstructured":"Lopez-Ramirez MA, Pham A, Girard R, Wyseure T, Hale P, Yamashita A et al (2019) Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood 133(3):193\u2013204. https:\/\/doi.org\/10.1182\/blood-2018-06-856062","journal-title":"Blood"},{"issue":"7","key":"9736_CR27","doi-asserted-by":"publisher","first-page":"e11786","DOI":"10.1371\/journal.pone.0011786","volume":"5","author":"L Goitre","year":"2010","unstructured":"Goitre L, Balzac F, Degani S, Degan P, Marchi S, Pinton P et al (2010) KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS ONE 5(7):e11786. https:\/\/doi.org\/10.1371\/journal.pone.0011786","journal-title":"PLoS ONE"},{"issue":"11","key":"9736_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.15252\/emmm.201505316","volume":"7","author":"S Marchi","year":"2015","unstructured":"Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S et al (2015) Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med 7(11):1403\u20131417. https:\/\/doi.org\/10.15252\/emmm.201505316","journal-title":"EMBO Mol Med"},{"issue":"7455","key":"9736_CR29","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M et al (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498(7455):492\u2013496. https:\/\/doi.org\/10.1038\/nature12207","journal-title":"Nature"},{"issue":"2","key":"9736_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/strokeaha.111.625467","volume":"43","author":"DA McDonald","year":"2012","unstructured":"McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH et al (2012) Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 43(2):571\u2013574. https:\/\/doi.org\/10.1161\/strokeaha.111.625467","journal-title":"Stroke"},{"issue":"27","key":"9736_CR31","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi L, Rudini N, Cuttano R, Giampietro C, Maddaluno L, Ferrarini L et al (2015) Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci USA 112(27):8421\u20138426. https:\/\/doi.org\/10.1073\/pnas.1501352112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9736_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/circulationaha.114.010403","volume":"131","author":"CC Gibson","year":"2015","unstructured":"Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J et al (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131(3):289\u2013299. https:\/\/doi.org\/10.1161\/circulationaha.114.010403","journal-title":"Circulation"},{"issue":"21","key":"9736_CR33","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1073\/pnas.1702942114","volume":"114","author":"S Nishimura","year":"2017","unstructured":"Nishimura S, Mishra-Gorur K, Park J, Surovtseva YV, Sebti SM, Levchenko A et al (2017) Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci USA 114(21):5503\u20135508. https:\/\/doi.org\/10.1073\/pnas.1702942114","journal-title":"Proc Natl Acad Sci USA"},{"key":"9736_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809155","author":"C Otten","year":"2018","unstructured":"Otten C, Knox J, Boulday G, Eymery M, Haniszewski M, Neuenschwander M et al (2018) Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201809155","journal-title":"EMBO Mol Med"},{"key":"9736_CR35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171178","author":"MA Lopez-Ramirez","year":"2017","unstructured":"Lopez-Ramirez MA, Fonseca G, Zeineddine HA, Girard R, Moore T, Pham A et al (2017) Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20171178","journal-title":"J Exp Med"},{"key":"9736_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.wneu.2015.11.003","volume":"88","author":"JM Zabramski","year":"2016","unstructured":"Zabramski JM, Kalani MYS, Filippidis AS, Spetzler RF (2016) Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg 88:631\u2013639. https:\/\/doi.org\/10.1016\/j.wneu.2015.11.003","journal-title":"World Neurosurg"},{"key":"9736_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2016.04.053","volume":"367","author":"M Reinhard","year":"2016","unstructured":"Reinhard M, Schuchardt F, Meckel S, Heinz J, Felbor U, Sure U et al (2016) Propranolol stops progressive multiple cerebral cavernoma in an adult patient. J Neurol Sci 367:15\u201317. https:\/\/doi.org\/10.1016\/j.jns.2016.04.053","journal-title":"J Neurol Sci"},{"issue":"11","key":"9736_CR38","doi-asserted-by":"publisher","first-page":"eaau0731","DOI":"10.1126\/sciadv.aau0731","volume":"4","author":"JP Choi","year":"2018","unstructured":"Choi JP, Wang R, Yang X, Wang X, Wang L, Ting KK et al (2018) Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci Adv. 4(11):eaau0731. https:\/\/doi.org\/10.1126\/sciadv.aau0731","journal-title":"Sci Adv."},{"key":"9736_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-019-00725-8","author":"L McKerracher","year":"2019","unstructured":"McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK et al (2019) A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease. Transl Stroke Res. https:\/\/doi.org\/10.1007\/s12975-019-00725-8","journal-title":"Transl Stroke Res"},{"issue":"1","key":"9736_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/jcmm.14773","volume":"24","author":"PV DiStefano","year":"2020","unstructured":"DiStefano PV, Glading AJ (2020) VEGF signalling enhances lesion burden in KRIT1 deficient mice. J Cell Mol Med 24(1):632\u2013639. https:\/\/doi.org\/10.1111\/jcmm.14773","journal-title":"J Cell Mol Med"},{"key":"9736_CR41","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1038\/ncomms7449","volume":"6","author":"B Lant","year":"2015","unstructured":"Lant B, Yu B, Goudreault M, Holmyard D, Knight JD, Xu P et al (2015) CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling. Nat Commun 6:6449. https:\/\/doi.org\/10.1038\/ncomms7449","journal-title":"Nat Commun"},{"issue":"16","key":"9736_CR42","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1242\/dev.02469","volume":"133","author":"JD Mably","year":"2006","unstructured":"Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman MC (2006) santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133(16):3139\u20133146. https:\/\/doi.org\/10.1242\/dev.02469","journal-title":"Development"},{"issue":"16","key":"9736_CR43","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/hmg\/ddn142","volume":"17","author":"BM Hogan","year":"2008","unstructured":"Hogan BM, Bussmann J, Wolburg H, Schulte-Merker S (2008) ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum Mol Genet 17(16):2424\u20132432. https:\/\/doi.org\/10.1093\/hmg\/ddn142","journal-title":"Hum Mol Genet"},{"issue":"6","key":"9736_CR44","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/humu.20996","volume":"30","author":"K Voss","year":"2009","unstructured":"Voss K, Stahl S, Hogan BM, Reinders J, Schleider E, Schulte-Merker S et al (2009) Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum Mutat 30(6):1003\u20131011. https:\/\/doi.org\/10.1002\/humu.20996","journal-title":"Hum Mutat"},{"issue":"2","key":"9736_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nm.1918","volume":"15","author":"B Kleaveland","year":"2009","unstructured":"Kleaveland B, Zheng X, Liu JJ, Blum Y, Tung JJ, Zou Z et al (2009) Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15(2):169\u2013176. https:\/\/doi.org\/10.1038\/nm.1918","journal-title":"Nat Med"},{"issue":"2","key":"9736_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ydbio.2011.12.006","volume":"362","author":"B Yoruk","year":"2012","unstructured":"Yoruk B, Gillers BS, Chi NC, Scott IC (2012) Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease. Dev Biol 362(2):121\u2013131. https:\/\/doi.org\/10.1016\/j.ydbio.2011.12.006","journal-title":"Dev Biol"},{"issue":"6","key":"9736_CR47","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1242\/dev.01036","volume":"131","author":"KJ Whitehead","year":"2004","unstructured":"Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131(6):1437\u20131448. https:\/\/doi.org\/10.1242\/dev.01036","journal-title":"Development"},{"issue":"2","key":"9736_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00335-005-0098-8","volume":"17","author":"NW Plummer","year":"2006","unstructured":"Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H et al (2006) Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17(2):119\u2013128. https:\/\/doi.org\/10.1007\/s00335-005-0098-8","journal-title":"Mamm Genome"},{"issue":"3\u20134","key":"9736_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1242\/dmm.001263","volume":"2","author":"G Boulday","year":"2009","unstructured":"Boulday G, Blecon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M et al (2009) Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Models Mech 2(3\u20134):168\u2013177. https:\/\/doi.org\/10.1242\/dmm.001263","journal-title":"Dis Models Mech"},{"issue":"116","key":"9736_CR50","doi-asserted-by":"publisher","first-page":"ra26","DOI":"10.1126\/scisignal.2000722","volume":"3","author":"Y He","year":"2010","unstructured":"He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H et al (2010) Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal 3(116):ra26. https:\/\/doi.org\/10.1126\/scisignal.2000722","journal-title":"Sci Signal"},{"issue":"2","key":"9736_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/hmg\/ddq433","volume":"20","author":"DA McDonald","year":"2011","unstructured":"McDonald DA, Shenkar R, Shi C, Stockton RA, Akers AL, Kucherlapati MH et al (2011) A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 20(2):211\u2013222. https:\/\/doi.org\/10.1093\/hmg\/ddq433","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9736_CR52","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/jci44393","volume":"121","author":"AC Chan","year":"2011","unstructured":"Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J et al (2011) Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest 121(5):1871\u20131881. https:\/\/doi.org\/10.1172\/jci44393","journal-title":"J Clin Invest"},{"issue":"5","key":"9736_CR53","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/s0002-9440(10)63409-8","volume":"165","author":"NW Plummer","year":"2004","unstructured":"Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA (2004) Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol 165(5):1509\u20131518. https:\/\/doi.org\/10.1016\/s0002-9440(10)63409-8","journal-title":"Am J Pathol"},{"issue":"1","key":"9736_CR54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/strokeaha.116.015013","volume":"48","author":"R Shenkar","year":"2017","unstructured":"Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y et al (2017) RhoA Kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke 48(1):187\u2013194. https:\/\/doi.org\/10.1161\/strokeaha.116.015013","journal-title":"Stroke"},{"issue":"3","key":"9736_CR55","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/strokeaha.118.024058","volume":"50","author":"R Shenkar","year":"2019","unstructured":"Shenkar R, Peiper A, Pardo H, Moore T, Lightle R, Girard R et al (2019) Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease. Stroke 50(3):738\u2013744. https:\/\/doi.org\/10.1161\/strokeaha.118.024058","journal-title":"Stroke"},{"issue":"9","key":"9736_CR56","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi A, Chen L, Two AM, Zhang H, Min W, Gunel M (2011) Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci USA 108(9):3737\u20133742. https:\/\/doi.org\/10.1073\/pnas.1012617108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9736_CR57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.devcel.2012.06.004","volume":"23","author":"X Zheng","year":"2012","unstructured":"Zheng X, Xu C, Smith AO, Stratman AN, Zou Z, Kleaveland B et al (2012) Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev Cell 23(2):342\u2013355. https:\/\/doi.org\/10.1016\/j.devcel.2012.06.004","journal-title":"Dev Cell"},{"issue":"23","key":"9736_CR58","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1093\/hmg\/ddu342","volume":"23","author":"TM Mleynek","year":"2014","unstructured":"Mleynek TM, Chan AC, Redd M, Gibson CC, Davis CT, Shi DS et al (2014) Lack of CCM1 induces hypersprouting and impairs response to flow. Hum Mol Genet 23(23):6223\u20136234. https:\/\/doi.org\/10.1093\/hmg\/ddu342","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9736_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41374-018-0030-y","volume":"99","author":"HA Zeineddine","year":"2019","unstructured":"Zeineddine HA, Girard R, Saadat L, Shen L, Lightle R, Moore T et al (2019) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest 99(3):319\u2013330. https:\/\/doi.org\/10.1038\/s41374-018-0030-y","journal-title":"Lab Invest"},{"issue":"2","key":"9736_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/dvg.20367","volume":"46","author":"S Claxton","year":"2008","unstructured":"Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M (2008) Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46(2):74\u201380. https:\/\/doi.org\/10.1002\/dvg.20367","journal-title":"Genesis"},{"issue":"13","key":"9736_CR61","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1084\/jem.20110398","volume":"208","author":"DA Ridder","year":"2011","unstructured":"Ridder DA, Lang MF, Salinin S, Roderer JP, Struss M, Maser-Gluth C et al (2011) TAK1 in brain endothelial cells mediates fever and lethargy. J Exp Med 208(13):2615\u20132623. https:\/\/doi.org\/10.1084\/jem.20110398","journal-title":"J Exp Med"},{"issue":"9","key":"9736_CR62","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday G, Rudini N, Maddaluno L, Bl\u00e9con A, Arnould M, Gaudric A et al (2011) Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med 208(9):1835\u20131847. https:\/\/doi.org\/10.1084\/jem.20110571","journal-title":"J Exp Med"},{"issue":"2","key":"9736_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0165-3806(85)90044-6","volume":"355","author":"PL Robertson","year":"1985","unstructured":"Robertson PL, Du Bois M, Bowman PD, Goldstein GW (1985) Angiogenesis in developing rat brain: an in vivo and in vitro study. Brain Res 355(2):219\u2013223. https:\/\/doi.org\/10.1016\/0165-3806(85)90044-6","journal-title":"Brain Res"},{"issue":"4","key":"9736_CR64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00005072-199904000-00001","volume":"58","author":"KH Plate","year":"1999","unstructured":"Plate KH (1999) Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neurol 58(4):313\u2013320. https:\/\/doi.org\/10.1097\/00005072-199904000-00001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"9736_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0925-4773(01)00471-3","volume":"108","author":"T Acker","year":"2001","unstructured":"Acker T, Beck H, Plate KH (2001) Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization. Mech Dev 108(1):45\u201357. https:\/\/doi.org\/10.1016\/S0925-4773(01)00471-3","journal-title":"Mech Dev"},{"issue":"5","key":"9736_CR66","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/strokeaha.108.538769","volume":"40","author":"C Shi","year":"2009","unstructured":"Shi C, Shenkar R, Du H, Duckworth E, Raja H, Batjer HH et al (2009) Immune response in human cerebral cavernous malformations. Stroke 40(5):1659\u20131665. https:\/\/doi.org\/10.1161\/strokeaha.108.538769","journal-title":"Stroke"},{"issue":"2","key":"9736_CR67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C et al (2016) B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models. J Neuroimmune Pharmacol 11(2):369\u2013377. https:\/\/doi.org\/10.1007\/s11481-016-9670-0","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"9736_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12975-017-0561-3","volume":"9","author":"R Girard","year":"2017","unstructured":"Girard R, Zeineddine HA, Fam MD, Mayampurath A, Cao Y, Shi C et al (2017) Plasma biomarkers of inflammation reflect seizures and hemorrhagic activity of cerebral cavernous malformations. Transl Stroke Res 9(1):34\u201343. https:\/\/doi.org\/10.1007\/s12975-017-0561-3","journal-title":"Transl Stroke Res"},{"issue":"5","key":"9736_CR69","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20947","volume":"60","author":"C Denier","year":"2006","unstructured":"Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M et al (2006) Genotype\u2013phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 60(5):550\u2013556. https:\/\/doi.org\/10.1002\/ana.20947","journal-title":"Ann Neurol"},{"issue":"4","key":"9736_CR70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000350042","volume":"4","author":"F Riant","year":"2013","unstructured":"Riant F, Bergametti F, Fournier HD, Chapon F, Michalak-Provost S, Cecillon M et al (2013) CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas. Mol Syndromol 4(4):165\u2013172. https:\/\/doi.org\/10.1159\/000350042","journal-title":"Mol Syndromol"},{"issue":"3","key":"9736_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2014.97","volume":"17","author":"R Shenkar","year":"2015","unstructured":"Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG et al (2015) Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med 17(3):188\u2013196. https:\/\/doi.org\/10.1038\/gim.2014.97","journal-title":"Genet Med"},{"key":"9736_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.119.027207","author":"C Cardoso","year":"2020","unstructured":"Cardoso C, Arnould M, De Luca C, Otten C, Abdelilah-Seyfried S, Heredia A et al (2020) Novel chronic mouse model of cerebral cavernous malformations. Stroke. https:\/\/doi.org\/10.1161\/strokeaha.119.027207","journal-title":"Stroke"},{"key":"9736_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.wneu.2019.12.172","volume":"136","author":"J Koskimaki","year":"2020","unstructured":"Koskimaki J, Zhang D, Carrion-Penagos J, Girard R, Piedad K, Polster SP et al (2020) Symptomatic brain hemorrhages from cavernous angioma after botulinum toxin injections, a role of TLR\/MEKK3 mechanism? Case report and review of the literature. World Neurosurg 136:7\u201311. https:\/\/doi.org\/10.1016\/j.wneu.2019.12.172","journal-title":"World Neurosurg"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-020-09736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-020-09736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T23:56:10Z","timestamp":1627084570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-020-09736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["9736"],"URL":"https:\/\/doi.org\/10.1007\/s10456-020-09736-8","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}